Lumos Pharma Inc (LUMO)
2.286
+0.03
(+1.55%)
USD |
NASDAQ |
Jun 28, 16:00
2.25
-0.04
(-1.57%)
After-Hours: 20:00
Lumos Pharma Free Cash Flow: -34.79M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -34.79M |
| December 31, 2023 | -31.10M |
| September 30, 2023 | -29.53M |
| June 30, 2023 | -27.23M |
| March 31, 2023 | -27.79M |
| December 31, 2022 | -26.62M |
| September 30, 2022 | -26.61M |
| June 30, 2022 | -28.14M |
| March 31, 2022 | -27.27M |
| December 31, 2021 | -29.65M |
| September 30, 2021 | -30.82M |
| June 30, 2021 | -23.38M |
| March 31, 2021 | -30.10M |
| December 31, 2020 | -23.03M |
| September 30, 2020 | -18.77M |
| June 30, 2020 | -21.04M |
| March 31, 2020 | -10.21M |
| December 31, 2019 | -9.09M |
| September 30, 2019 | -7.674M |
| June 30, 2019 | -20.80M |
| March 31, 2019 | -25.46M |
| December 31, 2018 | -37.95M |
| September 30, 2018 | -53.84M |
| June 30, 2018 | -45.97M |
| March 31, 2018 | -49.96M |
| Date | Value |
|---|---|
| December 31, 2017 | -48.32M |
| September 30, 2017 | -48.30M |
| June 30, 2017 | -54.46M |
| March 31, 2017 | -61.45M |
| December 31, 2016 | -68.19M |
| September 30, 2016 | -59.90M |
| June 30, 2016 | -54.90M |
| March 31, 2016 | -44.82M |
| December 31, 2015 | -28.08M |
| September 30, 2015 | 111.14M |
| June 30, 2015 | 109.88M |
| March 31, 2015 | 110.47M |
| December 31, 2014 | 107.37M |
| September 30, 2014 | -31.12M |
| June 30, 2014 | -28.85M |
| March 31, 2014 | -26.68M |
| December 31, 2013 | -27.20M |
| September 30, 2013 | -25.88M |
| June 30, 2013 | -21.98M |
| March 31, 2013 | -22.13M |
| December 31, 2012 | -21.79M |
| September 30, 2012 | -16.75M |
| June 30, 2012 | -16.85M |
| March 31, 2012 | -15.20M |
| December 31, 2011 | -13.23M |
Free Cash Flow Range, Past 5 Years
-34.79M
Minimum
Mar 2024
-7.674M
Maximum
Sep 2019
-24.18M
Average
-26.92M
Median
Free Cash Flow Benchmarks
| icad Inc | -5.964M |
| Perspective Therapeutics Inc | -23.28M |
| Palatin Technologies Inc | -33.83M |
| Bio-Path Holdings Inc | -8.92M |
| PDS Biotechnology Corp | -30.39M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.89M |
| Cash from Investing (Quarterly) | 1.00M |
| Cash from Financing (Quarterly) | -0.005M |
| Free Cash Flow Per Share (Quarterly) | -1.591 |
| Free Cash Flow to Equity (Quarterly) | -12.89M |
| Free Cash Flow Yield | -188.0% |